Literature DB >> 11748591

Growth inhibition of glioblastoma cells by human Pur(alpha).

N Darbinian1, G L Gallia, J King, L Del Valle, E M Johnson, K Khalili.   

Abstract

Pur(alpha) is a multifunctional DNA- and RNA-binding protein implicated in a variety of biological events including transcription and replication. Further, this protein has the ability to form a complex with several cellular proteins which are important for cell proliferation including the transcription factor, E2F-1. Pur(alpha) has a modular structure highlighted by alternating three basic aromatic class I and two acidic leucine-rich class II repeats in the central region of the protein. Here, we demonstrate that ectopic overexpression of Pur(alpha) suppresses proliferation of a variety of transformed and tumor cells including human glioblastoma. By utilizing various deletion mutants of Pur(alpha) in colony formation assay, we identified the region spanning the first class II repeat (residues 107-131) and the second class I repeat (residues 148-170) of Pur(alpha) which participate in growth inhibitory action of Pur(alpha). Results from protein transduction experiments using the synthetic peptides representing residues 109-131 and 123-154 of Pur(alpha) in fusion with the arginine rich domain of HIV-1 Tat revealed cellular internalization and nuclear appearance of the Tat-Pur(alpha) fusion peptide after 2 h and its detection in nuclei up to 24 h after treatment. Glioblastoma cells treated with Tat-Pur(alpha) (109-131) and Tat-Pur(alpha) (123-154) exhibited 41 and 47% decrease, respectively, in proliferation. Altogether these results illustrate the efficacy of Pur(alpha) in suppressing glioblastoma cell growth and provide evidence for the potential use of this protein and its derivative(s) in blocking proliferation of tumor cells. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748591     DOI: 10.1002/jcp.10029

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

1.  LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression.

Authors:  Minghua Wu; Kai Gan; Chen Huang; Yunlian Tang; Qiong Chen; Ke Tang; Xiaoling Li; Shourong Shen; Guiyuan Li
Journal:  J Neurooncol       Date:  2006-08-29       Impact factor: 4.130

Review 2.  PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions.

Authors:  Dianne C Daniel; Edward M Johnson
Journal:  Gene       Date:  2017-12-06       Impact factor: 3.688

Review 3.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

Review 4.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

5.  Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse.

Authors:  Kamel Khalili; Luis Del Valle; Vandhana Muralidharan; William J Gault; Nune Darbinian; Jessica Otte; Ellen Meier; Edward M Johnson; Dianne C Daniel; Yayoi Kinoshita; Shohreh Amini; Jennifer Gordon
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 6.  Multiple roles for Puralpha in cellular and viral regulation.

Authors:  Martyn K White; Edward M Johnson; Kamel Khalili
Journal:  Cell Cycle       Date:  2009-02-10       Impact factor: 4.534

7.  Protective role of Puralpha to cisplatin.

Authors:  Rafal Kaminski; Armine Darbinyan; Nana Merabova; Satish L Deshmane; Martyn K White; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

8.  Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.

Authors:  Mary B Dail; L Allen Shack; Janice E Chambers; Shane C Burgess
Journal:  Toxicol Sci       Date:  2008-09-16       Impact factor: 4.849

9.  Role of Puralpha in the modulation of homologous recombination-directed DNA repair by HIV-1 Tat.

Authors:  Huichen Wang; Martyn K White; Rafal Kaminski; Nune Darbinian; Shohreh Amini; Edward M Johnson; Kamel Khalili; Jay Rappaport
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

10.  Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ.

Authors:  Nune Darbinian; Yuri Popov; Kamel Khalili; Shohreh Amini
Journal:  Antiviral Res       Date:  2007-12-26       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.